These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32291170)

  • 21. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.
    Han HC; Hawkins NM; Pearman CM; Birnie DH; Krahn AD
    Europace; 2021 Jun; 23(23 Suppl 4):iv3-iv10. PubMed ID: 34051086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection.
    Rennert-May E; Raj SR; Leal J; Exner DV; Manns BJ; Chew DS
    Europace; 2021 May; 23(5):767-774. PubMed ID: 33554239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections.
    Welch M; Uslan DZ; Greenspon AJ; Sohail MR; Baddour LM; Blank E; Carrillo RG; Danik SB; Del Rio A; Hellinger W; Le KY; Miro JM; Naber C; Peacock JE; Vikram HR; Tseng CH; Prutkin JM;
    Pacing Clin Electrophysiol; 2014 Aug; 37(8):955-62. PubMed ID: 24665867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
    Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
    Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study.
    Wu PJ; Chen HC; Fang YN; Chong SZ; Chen YL; Chen MC
    BMC Infect Dis; 2023 Nov; 23(1):787. PubMed ID: 37957553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular implantable electronic device associated infections.
    Gandhi T; Crawford T; Riddell J
    Infect Dis Clin North Am; 2012 Mar; 26(1):57-76. PubMed ID: 22284376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
    Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
    Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.
    Rennert-May E; Chew D; Lu S; Chu A; Kuriachan V; Somayaji R
    Heart Rhythm; 2020 Jul; 17(7):1125-1131. PubMed ID: 32087358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study.
    Mateos Gaitán R; Boix-Palop L; Muñoz García P; Mestres CA; Marín Arriaza M; Pedraz Prieto Á; de Alarcón Gonzalez A; Gutiérrez Carretero E; Hernández Meneses M; Goenaga Sánchez MÁ; Cobo Belaustegui M; Oteo Revuelta JA; Gainzarain Arana JC; García Vázquez E; Martínez-Sellés M
    Europace; 2020 Jul; 22(7):1062-1070. PubMed ID: 32390046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices.
    Lin AY; Saul T; Aldaas OM; Lupercio F; Ho G; Pollema T; Pretorius V; Birgersdotter-Green U
    JACC Clin Electrophysiol; 2021 Jun; 7(6):755-763. PubMed ID: 33358664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
    Bloom HL; Constantin L; Dan D; De Lurgio DB; El-Chami M; Ganz LI; Gleed KJ; Hackett FK; Kanuru NK; Lerner DJ; Rasekh A; Simons GR; Sogade FO; Sohail MR;
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):133-42. PubMed ID: 20942819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac implantable electronic device infections: the enemy that lurks beneath the skin.
    Margey R
    J Long Term Eff Med Implants; 2010; 20(3):203-17. PubMed ID: 21395519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.
    Goldenberg GR; Barsheshet A; Bishara J; Kadmon E; Omelchencko A; Strasberg B; Golovchiner G
    J Interv Card Electrophysiol; 2020 Jun; 58(1):113-118. PubMed ID: 31227978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of bacteremia in patients living with cardiovascular implantable electronic devices.
    DeSimone DC; Sohail MR
    Heart Rhythm; 2016 Nov; 13(11):2247-2252. PubMed ID: 27546815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.
    Dai M; Cai C; Vaibhav V; Sohail MR; Hayes DL; Hodge DO; Tian Y; Asirvatham R; Cochuyt JJ; Huang C; Friedman PA; Cha YM
    JACC Clin Electrophysiol; 2019 Sep; 5(9):1071-1080. PubMed ID: 31537337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.
    Uslan DZ; Dowsley TF; Sohail MR; Hayes DL; Friedman PA; Wilson WR; Steckelberg JM; Baddour LM
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):407-13. PubMed ID: 19793360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
    Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
    Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of mortality in patients with cardiovascular implantable electronic device infections.
    Habib A; Le KY; Baddour LM; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Sohail MR;
    Am J Cardiol; 2013 Mar; 111(6):874-9. PubMed ID: 23276467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac implantable electronic device infection in patients with end-stage renal disease.
    Guha A; Maddox WR; Colombo R; Nahman NS; Kintziger KW; Waller JL; Diamond M; Murphy M; Kheda M; Litwin SE; Sorrentino RA
    Heart Rhythm; 2015 Dec; 12(12):2395-401. PubMed ID: 26253036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.